These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8160253)

  • 21. Pharmacokinetic fluvoxamine-clomipramine interaction with favorable therapeutic consequences in therapy-resistant depressive patient.
    Conus P; Bondolfi G; Eap CB; Macciardi F; Baumann P
    Pharmacopsychiatry; 1996 May; 29(3):108-10. PubMed ID: 8738315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. "Should I stay or should I go?" Coming off methadone and buprenorphine treatment.
    Winstock AR; Lintzeris N; Lea T
    Int J Drug Policy; 2011 Jan; 22(1):77-81. PubMed ID: 20956077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Population pharmacokinetics of methadone in opiate users: characterization of time-dependent changes.
    Rostami-Hodjegan A; Wolff K; Hay AW; Raistrick D; Calvert R; Tucker GT
    Br J Clin Pharmacol; 1999 Jul; 48(1):43-52. PubMed ID: 10383559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Major depressive disorder and patient satisfaction in relation to methadone pharmacokinetics and pharmacodynamics in stabilized methadone maintenance patients.
    Elkader AK; Brands B; Dunn E; Selby P; Sproule BA
    J Clin Psychopharmacol; 2009 Feb; 29(1):77-81. PubMed ID: 19142113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of methadone on emotional reactivity.
    Savvas SM; Somogyi AA; White JM
    Addiction; 2012 Feb; 107(2):388-92. PubMed ID: 21883603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir.
    Clarke S; Mulcahy F; Bergin C; Reynolds H; Boyle N; Barry M; Back DJ
    Clin Infect Dis; 2002 Apr; 34(8):1143-5. PubMed ID: 11915005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DSM-III personality type and dose levels in methadone maintenance patients.
    Treece C; Nicholson B
    J Nerv Ment Dis; 1980 Oct; 168(10):621-8. PubMed ID: 7420071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients.
    Hiltunen AJ; Lafolie P; Martel J; Ottosson EC; Boreus LO; Beck O; Borg S; Hjemdahl P
    Psychopharmacology (Berl); 1995 Mar; 118(2):122-6. PubMed ID: 7617797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prescribing methadone for the opiate addict: a problem of dosage conversion.
    Johns AR; Gossop M
    Drug Alcohol Depend; 1985 Sep; 16(1):61-6. PubMed ID: 4064909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction between fluvoxamine and imipramine/desipramine in four patients.
    Spina E; Campo GM; Avenoso A; Pollicino MA; Caputi AP
    Ther Drug Monit; 1992 Jun; 14(3):194-6. PubMed ID: 1412604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone maintenance treatment, criminality and overdose-related deaths. An ecological study, 1983-1999.
    Niveau G; Rougemont AL; La Harpe R
    Eur J Public Health; 2002 Sep; 12(3):224-7. PubMed ID: 12232963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors affecting the dose of methadone among patients receiving methadone maintenance therapy in Taiwan.
    Li DJ; Chung KS; Wu HC; Hsu CY; Yen CF
    Am J Addict; 2018 Apr; 27(3):225-230. PubMed ID: 29569392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased trimipramine plasma levels during fluvoxamine comedication.
    Seifritz E; Holsboer-Trachsler E; Hemmeter U; Eap CB; Baumann P
    Eur Neuropsychopharmacol; 1994 Mar; 4(1):15-20. PubMed ID: 8204992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmentative effects of fluvoxamine on duloxetine plasma levels in depressed patients.
    Paulzen M; Finkelmeyer A; Grözinger M
    Pharmacopsychiatry; 2011 Nov; 44(7):317-23. PubMed ID: 21979923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The influence of lithium on fluvoxamine therapeutic efficacy and pharmacokinetics in depressed patients on combined fluvoxamine-lithium therapy.
    Miljković BR; Pokrajac M; Timotijević I; Varagić V
    Int Clin Psychopharmacol; 1997 Jul; 12(4):207-12. PubMed ID: 9347381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone.
    Altice FL; Friedland GH; Cooney EL
    AIDS; 1999 May; 13(8):957-62. PubMed ID: 10371177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug interactions in methadone therapy].
    Freye E
    Z Arztl Fortbild (Jena); 1992 Jul; 86(14):731-7. PubMed ID: 1529624
    [No Abstract]   [Full Text] [Related]  

  • 38. Methadone: a new old drug with promises and pitfalls.
    Trafton JA; Ramani A
    Curr Pain Headache Rep; 2009 Feb; 13(1):24-30. PubMed ID: 19126367
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Better understanding of methadone].
    Ouellet JM
    Perspect Infirm; 2005; 2(3):42-3. PubMed ID: 15686212
    [No Abstract]   [Full Text] [Related]  

  • 40. Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.
    Mouly S; Bloch V; Peoc'h K; Houze P; Labat L; Ksouda K; Simoneau G; Declèves X; Bergmann JF; Scherrmann JM; Laplanche JL; Lepine JP; Vorspan F
    Br J Clin Pharmacol; 2015 Jun; 79(6):967-77. PubMed ID: 25556837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.